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Objective: This report describes a case of serous ovarian carcinoma with occult serous tubal intra-
epithelial carcinoma (STIC), which presented as atypical glandular cells favor neoplasia (AGC-FN) with
Pap cytology and dermatomyositis.
Case report: A 48-year-old woman presented with symptoms of dermatomyositis. An AGC-FN result from
a Pap smear, with an absence of a cervical or endometrial lesion was noted. After cancer surveillance,
ovarian high grade serous carcinoma associated with serous tubal intraepithelial carcinoma was diag-
nosed. Two weeks following surgical excision of the carcinoma, dramatic remission of the dermato-
myositis symptoms was evident.
Conclusion: The patient had serous carcinoma of the ovary with tubal STIC, which presented as der-
matomyositis. The AGC-FN identiﬁed from a Pap smear hinted at a diagnosis of ovarian carcinoma. These
presentations point to an occult malignancy in the genital tract and demand careful diagnostic workup.
Copyright © 2015, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All
rights reserved.Introduction
Dermatomyositis is a rare microangiopathy that is frequently
associated with concomitant cancers. Over-activation of comple-
ment induced by tumor or virus molecules is its proposed patho-
genesis, and results in lysis of endomysial capillaries and muscle
ischemia [1]. As many as 25% of dermatomyositis cases are asso-
ciated with an occult neoplasm. The most common cancers for
these patients are ovarian (13.3e26%) and breast cancer (13.5%) for
women, and lung cancer (11.9%) for men [2]. Gastrointestinal tract
cancer (25.4%) [2] and a high incidence of nasopharyngeal cancer
have been noted in Asians (13.3%) [3]. This report describes an
interesting case of dermatomyositis-related ovarian high grade
serous carcinoma, with a unique cervical cytological presentationnd Gynecology, Buddhist Tzu
, Hualien, Taiwan.
bstetrics & Gynecology. Publishedof atypical glandular cell favor neoplasia (AGC-FN) and a concom-
itant serous intraepithelial carcinoma (STIC) in a fallopian tube.Case report
A 48-year-old woman suffered frommultiple erythematous skin
rashes for roughly 2 months prior to admission (Fig. 1). She also
complained of general weakness and soreness, and difﬁculty
climbing stairs, and lifting incapable patients at work. This condi-
tion caused problems when eating and raising her hands and legs.
Her speech and hearing were also impaired. She was unable to
make a sound while trying to scream and her hearing was mufﬂed.
Her personal and family history were unremarkable.
Geographic erythematous rashes on the forehead, periorbital
area, face, anterior chest (Fig. 1), knuckles, and distal parts of the
upper extremities were noted. Gottron's papules were identiﬁed on
bilateral knuckles; proximal interphalangeal joints had scattered
lesions, as did periungual areas; and palms and soles were tender.by Elsevier Taiwan LLC. All rights reserved.
Fig. 1. Initial presentation of asymmetric erythematous rash on the forehead, face,
neck, and anterior chest.
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legs. No obvious Gowers' sign was noted. Laboratory investigations
revealed elevated levels of aspartate aminotransferase (148 IU/L),
alanine aminotransferase (130 IU/L), total creatine kinase (1190 U/
L; normal range, 26e192), and lactate dehydrogenase (469 U/L:
normal range, 100e190). Immunological studies revealed a high
antinuclear antibody level (1:1280), but anti-Jo1, anti-Scl70, anti-
CENPB, anti-SSA, anti-SSB, anti-Sm, anti-RNP, and anti-nDNA
were all negative. Tumor markers revealed elevated CA-125 levels
(543 IU/ml; normal range, 0e35).
Before admission, under the diagnosis of dermatomyositis,
50 mg/day azathioprine and 15 mg 3 times/day prednisolone had
been prescribed, but muscle strength and skin rashes improved
little after treatment for 3 weeks. Tests for cancer, including upper
gastrointestinal endoscopy, abdominal ultrasound, and mammog-
raphy were negative. A Pap smear revealed AGC-FN (Fig. 2). The
patient was referred to the Gynecology Oncology division; colpo-
scopic cervical biopsy and endocervical curettage were negative.
Transvaginal ultrasound and MRI revealed bilateral lobulated soft
tissue masses with cystic components over adnexal regions with
strong contrast enhancement (Fig. 3A and 3B).
Under the impression of ovarian cancer, the patient under-
went debulking surgery with total hysterectomy, bilateral
salpingo-oophorectomy and pelvic lymph-node dissection, and a
partial omentectomy. During the exploratory laparotomy, carci-
nomatosis, right side tumor rupture, and severe adhesions overFig. 2. Pap smear revealed atypical glandular cells with smalthe bilateral adnexa and cul-de-sac were noted. Carcinomatosis
was identiﬁed with tumor rupture on its right side with severe
adhesion over the bilateral adnexal and cul-de-sac. Fallopian
tubes could not be identiﬁed clearly. Frozen sections revealed
adenocarcinoma. Finally, pathological analysis revealed FIGO
stage IIIc high grade ovarian serous carcinoma (Fig. 4A) with
omentum and bilateral common iliac lymph-node involvement.
Two weeks following surgery, signs and symptoms of dermato-
myositis, including skin rash, hearing disturbance, and impaired
liver function, disappeared. The patient underwent six cycles of
dose-dense chemotherapy with paclitaxel (80 mg/m2) and car-
boplatin (AUC ¼ 5). All laboratory data for dermatomyositis,
including antinuclear antibody level returned to normal. The
CA125 level dropped to a normal level after a second course of
chemotherapy. Complete remission was maintained at 15 months
after surgery.Discussion
Dermatomyositis, an acute idiopathic inﬂammatory disorder,
has a low prevalence of 0.6e1.0 per 100,000 people [1]. Although it
occurs in all age groups, prevalence is higher in women than in
men. This disease is characterized by skeletal muscle inﬂammation
with progressive symmetrical proximal myopathy and classical
cutaneous manifestations of heliotrope rashes. The skin rash typi-
cally involves the upper eyelids (and is associated with edema), the
face, neck, and anterior chest (V sign), and back and shoulders
(shawl sign), as well as the knees, elbows, and malleoli. Signs and
symptoms of dermatomyositis may overlap with those of systemic
sclerosis and mixed connective-tissue disease [4,5]. Unlike cases of
systemic lupus erythematosus, which involves the phalanges but
spares the knuckles, the skin rash in dermatomyositis involves only
the knuckles of the hand [4,6].
The spectrum of cancers that are associated with dermatomy-
ositis reﬂects the prevalence of cancers in a particular population.
In Taiwan, patients with dermatomyositis have a high risk of
nasopharyngeal cancer, breast cancer, and lung cancer, with odd
ratios of risks of 66, 10, and 31, respectively [7]. Thorough physical
and laboratory tests for malignancies have been recommended for
at least 5 years of follow-up [7]. Dermatomyositis may precede the
development of malignancies by several months [2], and its early
diagnosis improves outcome. Dermatomyositis may also present
concurrently with a malignancy or after the malignancy has been
treated primarily [8]. Women with dermatomyositis have a much
higher incidence of ovarian cancer (13.3e26%) [9,10] than the
general female population (1.0e1.4%) [11]. For reasons unknown,
cancer mortality rate for dermatomyositis patients is higher than ofl eccentric hyperchromatic nuclei and clean background.
Fig. 3. (A) Transvaginal sonography revealed heterogeneous tumor of bilateral adnexa, 46.8  38.7 mm, left, and 87.7  48.0 mm, right. (B) Magnetic resonance imaging (T2)
showed bilateral lobulated adnexal solid tumors (arrows) (left side: 58.28  40.19 mm, right side: 59.43  45.21 mm) with cystic parts and strong contrast enhancement.
Fig. 4. (A) Histology of the resected ovarian tumor showed high grade serous carcinoma; (B) positive immunostain showing p53; (C) STIC was found in the lumen of the adjacent
fallopian tube (blue rectangle); (D) positive immunostain showing the secretory cell speciﬁc marker PAX8; (E) immunostain showing p53; (F) the p53 signature was also noted in
the adjacent tubal epithelium.
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ever, this patient achieved a favorable outcome.
An increasing amount of clinical pathological evidence supports
the hypothesis that the fallopian tube epithelium is the origin of
high-grade serous carcinoma of the ovaries [12e14]. Notably, STIC
is the earliest morphologically recognizable form of tubal high-grade serous carcinoma, and it is considered the precursor of se-
rous ovarian or peritoneal carcinoma. Most STICs exhibit abnormal
immunohistochemical expression of tumor suppressor protein p53
(the “P53 signature”) [15]. In reported cases, p53 mutations were
found in 57% of STICs and identical mutations were found in
concomitant high-grade serous carcinoma of the ovary and
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of the fallopian tube (Fig. 4C) with evident paired box gene 8 (PAX8)
expression (Fig. 4D). Notably, PAX8 is a speciﬁc marker for secretory
cells of the fallopian tube epithelium and for high grade ovarian
serous carcinoma [16]. Positive p53 immunostaining was obvious
in the ovarian tumor (Fig. 4B) and STIC (Fig. 4E), and the p53
signature was observed in the adjacent benign-looking tube
epithelium (Fig. 4F). The p53 signature with or without secretory
cell outgrowth is commonly noted in the epithelium of grossly
normal fallopian tubes and endometrium, and may be associated
with early tumor initiation [17,18].
In total, 0.1e2.9% of screening Pap smear tests identiﬁes
atypical glandular cells (AGC) [19,20]. The reported risk for pre-
malignant and malignant tumors is 17e59% [21e24] and may
include cancers of the entire genital tract. A systematic review of
gynecological cancer cases in 6829 women, based on AGC-
positive Pap smear results, revealed endometrial cancer in
57.6%, cervical cancer in 29%, ovarian or fallopian tube carcinoma
in 6.4%, and other cancers in 6.9% [20]. Another comprehensive
retrospective study of the signiﬁcance of AGC-FN Pap smear
diagnosis estimated the rate of fallopian cancer at as high as 25%
when endometrial origin was excluded. In one investigation of 10
fallopian tube carcinomas, preoperative cytological diagnosis
from the vagina, cervix, endocervix, and endometrium identiﬁed
malignant cells in six cases [25]. Accordingly, AGC-FN and
adenocarcinoma-positive Pap smear results provide important
indications of possible tubal carcinoma or ovarian cancer with
tubal involvement, especially with a clean smear background and
negative endometrial sampling [26]. Indeed, in this case, tumor
cells slugged from the STIC were found in the fallopian tube
(Fig. 4F). The slugged cancer cells, like oocytes and embryos, can
be transferred to the uterine cavity through movement of cilia
and peristalsis of the tube, potentially becoming trapped in cer-
vical mucus. Beyond the standard management of an AGC-FN-
positive Pap smear result with colposocopy and endometrial bi-
opsy, additional surveys, including transvaginal ultrasound, are
mandatory.
To the best of the authors' knowledge, this report is the ﬁrst
demonstration of the p53 signature and STIC in a Taiwanese case of
a high-grade ovarian serous carcinoma. Although this tumor may
not be frequently associated with AGC-FN and dermatomyositis,
when dermatomyositis or an AGC-FN-positive Pap smear result is
encountered, the possibility of occult STIC or an ovarian carcinoma
should be considered.Conﬂicts of interest
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